Article Details

Magenta Therapeutics unveils plans to raise $100M in IPO weeks after a crossover round

Retrieved on: 2018-05-24 05:00:00

Tags for this article:

Click the tags to see associated articles and topics

Magenta Therapeutics unveils plans to raise $100M in IPO weeks after a crossover round. View article details on hiswai:

Excerpt

<div>... cash from some marquee investors that include GV – the venture group formerly known as <b>Google Ventures</b> – and in-licensing a mid-stage drug that ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up